Earnings Feed
Start Free
Home/Filings/4/0001181431-11-011588
4//SEC Filing

THREE ARCH MANAGEMENT III LLC 4

Accession 0001181431-11-011588

CIK 0001427925other
View on SEC.govCompany Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 6:25 PM ET

Size

64.8 KB

Accession

0001181431-11-011588

Insider Transaction Report

Form 4
Period: 2011-02-16
ACELRX PHARMACEUTICALS INCACRX
THREE ARCH MANAGEMENT III LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+1,223,983$6,119,915→ 3,637,169 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+583,255→ 583,255 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+25,106→ 56,463 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+44,702→ 101,165 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+1,430→ 129,737 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−311,384→ 0 total(indirect: See Footnote)
    → Common Stock (466,990 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−44,702→ 0 total(indirect: See Footnote)
    → Common Stock (44,702 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−831,466→ 0 total(indirect: See Footnote)
    → Common Stock (831,466 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (24,608 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−114,123→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (114,123 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+114,123→ 114,123 total(indirect: See Footnote)
    → Common Stock (114,123 underlying)
  • Conversion

    Common Stock

    2011-02-16+31,357→ 31,357 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+466,990→ 1,050,245 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+831,466→ 1,881,711 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+504,860→ 2,386,571 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+26,615→ 2,413,186 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−16,741→ 0 total(indirect: See Footnote)
    → Common Stock (25,106 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (457,716 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−6,135→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (6,135 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+6,135→ 6,135 total(indirect: See Footnote)
    → Common Stock (6,135 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−4,838→ 1,297 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (4,838 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−1,297→ 0 total(indirect: See Footnote)
    → Common Stock (1,297 underlying)
  • Conversion

    Common Stock

    2011-02-16+27,142→ 128,307 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+65,806$329,030→ 195,543 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−22,959→ 0 total(indirect: See Footnote)
    → Common Stock (31,357 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−427,040→ 0 total(indirect: See Footnote)
    → Common Stock (583,255 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−89,993→ 24,130 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (89,993 underlying)
WAN MARK A
Director
Transactions
  • Conversion

    Common Stock

    2011-02-16+583,255→ 583,255 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+25,106→ 56,463 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+44,702→ 101,165 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+504,860→ 2,386,571 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+26,615→ 2,413,186 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+1,223,983$6,119,915→ 3,637,169 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−16,741→ 0 total(indirect: See Footnote)
    → Common Stock (25,106 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−22,959→ 0 total(indirect: See Footnote)
    → Common Stock (31,357 underlying)
  • Conversion

    Common Stock

    2011-02-16+31,357→ 31,357 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−427,040→ 0 total(indirect: See Footnote)
    → Common Stock (583,255 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−44,702→ 0 total(indirect: See Footnote)
    → Common Stock (44,702 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−6,135→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (6,135 underlying)
  • Conversion

    Common Stock

    2011-02-16+466,990→ 1,050,245 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+831,466→ 1,881,711 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+27,142→ 128,307 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+1,430→ 129,737 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+65,806$329,030→ 195,543 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−311,384→ 0 total(indirect: See Footnote)
    → Common Stock (466,990 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−831,466→ 0 total(indirect: See Footnote)
    → Common Stock (831,466 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (24,608 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (457,716 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+6,135→ 6,135 total(indirect: See Footnote)
    → Common Stock (6,135 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−4,838→ 1,297 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (4,838 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−1,297→ 0 total(indirect: See Footnote)
    → Common Stock (1,297 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−114,123→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (114,123 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+114,123→ 114,123 total(indirect: See Footnote)
    → Common Stock (114,123 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−89,993→ 24,130 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (89,993 underlying)
JAEGER WILFRED E
10% Owner
Transactions
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−831,466→ 0 total(indirect: See Footnote)
    → Common Stock (831,466 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+6,135→ 6,135 total(indirect: See Footnote)
    → Common Stock (6,135 underlying)
  • Conversion

    Common Stock

    2011-02-16+25,106→ 56,463 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+831,466→ 1,881,711 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+27,142→ 128,307 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+504,860→ 2,386,571 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+1,430→ 129,737 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+26,615→ 2,413,186 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+65,806$329,030→ 195,543 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+1,223,983$6,119,915→ 3,637,169 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−22,959→ 0 total(indirect: See Footnote)
    → Common Stock (31,357 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−427,040→ 0 total(indirect: See Footnote)
    → Common Stock (583,255 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−16,741→ 0 total(indirect: See Footnote)
    → Common Stock (25,106 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−311,384→ 0 total(indirect: See Footnote)
    → Common Stock (466,990 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−44,702→ 0 total(indirect: See Footnote)
    → Common Stock (44,702 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (457,716 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−4,838→ 1,297 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (4,838 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−1,297→ 0 total(indirect: See Footnote)
    → Common Stock (1,297 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−114,123→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (114,123 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+114,123→ 114,123 total(indirect: See Footnote)
    → Common Stock (114,123 underlying)
  • Conversion

    Common Stock

    2011-02-16+31,357→ 31,357 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+583,255→ 583,255 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+466,990→ 1,050,245 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+44,702→ 101,165 total(indirect: See Footnote)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (24,608 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−6,135→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (6,135 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−89,993→ 24,130 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (89,993 underlying)
THREE ARCH ASSOCIATES III LP
10% Owner
Transactions
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−89,993→ 24,130 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (89,993 underlying)
  • Conversion

    Common Stock

    2011-02-16+466,990→ 1,050,245 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+831,466→ 1,881,711 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+504,860→ 2,386,571 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−311,384→ 0 total(indirect: See Footnote)
    → Common Stock (466,990 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−831,466→ 0 total(indirect: See Footnote)
    → Common Stock (831,466 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−4,838→ 1,297 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (4,838 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−114,123→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (114,123 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+6,135→ 6,135 total(indirect: See Footnote)
    → Common Stock (6,135 underlying)
  • Conversion

    Common Stock

    2011-02-16+31,357→ 31,357 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+583,255→ 583,255 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+25,106→ 56,463 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+44,702→ 101,165 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+27,142→ 128,307 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+1,430→ 129,737 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+26,615→ 2,413,186 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+65,806$329,030→ 195,543 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+1,223,983$6,119,915→ 3,637,169 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−22,959→ 0 total(indirect: See Footnote)
    → Common Stock (31,357 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−427,040→ 0 total(indirect: See Footnote)
    → Common Stock (583,255 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−16,741→ 0 total(indirect: See Footnote)
    → Common Stock (25,106 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−44,702→ 0 total(indirect: See Footnote)
    → Common Stock (44,702 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (24,608 underlying)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (457,716 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−6,135→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (6,135 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−1,297→ 0 total(indirect: See Footnote)
    → Common Stock (1,297 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+114,123→ 114,123 total(indirect: See Footnote)
    → Common Stock (114,123 underlying)
THREE ARCH PARTNERS III LP
10% Owner
Transactions
  • Conversion

    Common Stock

    2011-02-16+31,357→ 31,357 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+831,466→ 1,881,711 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+1,430→ 129,737 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+26,615→ 2,413,186 total(indirect: See Footnote)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (457,716 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−89,993→ 24,130 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (89,993 underlying)
  • Conversion

    Common Stock

    2011-02-16+25,106→ 56,463 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+44,702→ 101,165 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+65,806$329,030→ 195,543 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2011-02-16$5.00/sh+1,223,983$6,119,915→ 3,637,169 total(indirect: See Footnote)
  • Conversion

    Convertible Promissory Note

    2011-02-16→ 0 total(indirect: See Footnote)
    → Common Stock (24,608 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−6,135→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (6,135 underlying)
  • Sale

    Series C Convertible Preferred Stock

    2011-02-16−4,838→ 1,297 total(indirect: See Footnote)
    Exercise: $5.00→ Common Stock (4,838 underlying)
  • Exercise of In-Money

    Warrant to purchase Series C Convertible Preferred Stock

    2011-02-16−114,123→ 0 total(indirect: See Footnote)
    → Series C Preferred Stock (114,123 underlying)
  • Conversion

    Common Stock

    2011-02-16+583,255→ 583,255 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+466,990→ 1,050,245 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+27,142→ 128,307 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2011-02-16+504,860→ 2,386,571 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−22,959→ 0 total(indirect: See Footnote)
    → Common Stock (31,357 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2011-02-16−427,040→ 0 total(indirect: See Footnote)
    → Common Stock (583,255 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−16,741→ 0 total(indirect: See Footnote)
    → Common Stock (25,106 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-16−311,384→ 0 total(indirect: See Footnote)
    → Common Stock (466,990 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−44,702→ 0 total(indirect: See Footnote)
    → Common Stock (44,702 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−831,466→ 0 total(indirect: See Footnote)
    → Common Stock (831,466 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+6,135→ 6,135 total(indirect: See Footnote)
    → Common Stock (6,135 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2011-02-16−1,297→ 0 total(indirect: See Footnote)
    → Common Stock (1,297 underlying)
  • Exercise of In-Money

    Series C Convertible Preferred Stock

    2011-02-16+114,123→ 114,123 total(indirect: See Footnote)
    → Common Stock (114,123 underlying)
Footnotes (18)
  • [F1]The shares reflect the automatic conversion of 22,959 shares of the Issuer's Series A Convertible Preferred Stock for 31,357 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  • [F10]Immediately convertible into shares of the Issuer's Common Stock.
  • [F11]These shares have no expiration date.
  • [F12]A note with the principal amount plus accrued interest of $98,433.72 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00 which is of 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  • [F13]A note with the principal amount plus accrued interest of $1,830,866.97 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00 which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  • [F14]The exercise price is $3.942 per share.
  • [F15]Immediately exercisable prior to and contingent upon the closing of the Issuer's initial public offering.
  • [F16]Pursuant to its terms, the warrant was to be terminated at the closing of the Issuer's initial public offering. Holder elected to net exercise the warrants immediately prior to the closing of the Issuer's initial public offering. In the event the Issuer's public offering did not occur, the warrant would have terminated on September 14, 2017, unless earlier terminated in accordance with its terms, in a liquidation or change of control transaction.
  • [F2]The shares are held by Three Arch Associates III, L.P. The voting and dispositive decisions with respect to the shares held by Three Arch Associates III, L.P., are made by the following Managing Members of its general partner Three Arch Management III, L.L.C.: Mark Wan and Wilfred Jaeger, each of whom disclaims beneficial ownership of such shares.
  • [F21]These shares represent the net exercise of a warrant to purchase Series C Convertible Preferred Stock for an acquisition of 1,297 shares of Series C Convertible Preferred Stock of the Issuer.
  • [F22]These shares represent the net exercise of a warrant to purchase Series C Convertible Preferred Stock for an acquisition of 24,130 shares of Series C Convertible Preferred Stock of the Issuer.
  • [F3]The shares reflect the automatic conversion of 427,040 shares of the Issuer's Series A Convertible Preferred Stock for 583,255 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  • [F4]The shares are held by Three Arch Partners III, L.P. The voting and dispositive decisions with respect to the shares held by Three Arch Partners III, L.P., are made by the following Managing Members of its general partner Three Arch Management III, L.L.C.: Mark Wan and Wilfred Jaeger, each of whom disclaims beneficial ownership of such shares.
  • [F5]The shares reflect the automatic conversion of 16,741 shares of the Issuer's Series B Convertible Preferred Stock for 25,106 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  • [F6]The shares reflect the automatic conversion of 311,384 shares of the Issuer's Series B Convertible Preferred Stock for 466,990 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  • [F7]The shares reflect the automatic conversion of shares of the Issuer's Series C Convertible Preferred Stock into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering.
  • [F8]Notes and accrued interest in the aggregate of $108,572.10 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  • [F9]Notes and accrued interest in the aggregate of $2,019,445.02 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.

Documents

1 file

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001256738

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:25 PM ET
Size
64.8 KB
View on SEC.gov